Ensuring Informed CML Care from Diagnosis Onward
Opinion
Video
Experts on chronic myeloid leukemia delve into the important role of informed shared decision-making in the optimal treatment of patients with CML.
This program was made possible with support from Novartis Pharmaceuticals.
Video content above is prompted by the following:
- As patients progress through their CML journey, how does the focus of shared decision-making evolve between the patient, caregiver, and healthcare team? What are some of the key challenges or changes you've observed in the patient, physician, and caregiver role over time?
- What advice would you direct to patients and caregivers in navigating these changes?
- What advice would you direct to patients and caregivers in navigating these changes?
Related Content
What Is CAR-T Cell Therapy, and What Can Patients With Cancer Expect?September 16th 2022
New Treatments Lend a Positive Outlook to Patients With GVHDFebruary 28th 2022
View additional resources on CureToday.com
Advertisement
Advertisement








